Back to Home
BrandRADAR
Pet· Ingredient Technology· Sustainability Signal

The First Lab-Grown Dog Food Did Launch—But It Wasn't the Product Most People Think: Calysta's FeedKind Pet Protein

The first lab-grown dog food did reach market — but it wasn't the cultured-muscle steak most coverage implied. It was a cultured-meat treat, and the distinction matters for the category's next five years.

July 12, 2026

In February 2025, two unusual dog-food launches appeared within three weeks of each other.

The first was Chick Bites, a limited-edition dog treat sold in the United Kingdom and containing chicken grown from animal cells.

The second was MicroBell, a complete vegan dry dog food containing a protein produced by fermenting microorganisms without using animals or agricultural crops.

Both were described through language such as:

  • Cultured protein
  • Fermentation
  • Cellular agriculture
  • Animal-free protein
  • Bioreactor production
  • Sustainable pet nutrition

But they were not the same technology.

Chick Bites contained cultivated meat.

MicroBell contained microbial protein.

That distinction matters because cultivated meat and fermentation-derived protein begin with completely different biological systems.

One grows animal cells.

The other grows microorganisms.

A year later, FORZA10 and BeneMeat introduced Coolty Meat, a complete wet dog food containing 26% cultivated meat and described by its developers as the first complete cultivated-meat dog food commercially launched in the European Union.

The category therefore did not experience one simple "first."

It experienced three:

  • The first commercial pet product containing cultivated meat
  • The first complete dog food containing FeedKind fermented microbial protein
  • The first complete cultivated-meat dog food launched in the EU

This is one signal from the Consensys Innovation Signals Engine, which continuously scans a library of more than one million products worldwide for emerging shifts in formulation, positioning and consumer demand.

Signal: Alternative Proteins Splitting Into Distinct Commercial Categories

The original claim combines two different technologies

The original research row describes Calysta and Marsapet's FeedKind Pet product as the first commercially available dog food made with lab-grown meat.

That is incorrect.

Calysta describes FeedKind as a protein created by controlled fermentation of naturally occurring microorganisms.

The ingredient does not consist of chicken, beef or other animal cells.

It is a single-cell protein produced by growing bacteria in a controlled fermentation system. Calysta says the process uses no animal-derived ingredients, no plant ingredients and no agricultural land.

Technology: Microbial fermentation

Biological input: Naturally occurring microorganisms

Final ingredient: Concentrated microbial protein

Animal cells: None

Cultivated meat: No

Evidence Correction: FeedKind Is Fermented Microbial Protein, Not Lab-Grown Meat

Calling FeedKind cultivated meat would be like calling yeast protein cultivated chicken because both are grown inside fermentation equipment.

The production hardware can look similar.

The biology is fundamentally different.

What is cultivated meat?

Cultivated meat is produced by growing animal cells outside the animal.

A developer typically begins with cells obtained from an animal source, then supplies those cells with:

  • Nutrients
  • Amino acids
  • Vitamins
  • Minerals
  • Energy sources
  • Controlled temperature and oxygen conditions

The cells multiply inside a bioreactor and produce animal-cell biomass.

The resulting material is biologically animal tissue or animal-cell material, even though the animal itself was not raised and slaughtered in the conventional way.

Innovation Type: Animal-Cell Agriculture

Cultivated chicken begins with chicken cells.

Cultivated beef begins with cattle cells.

The central promise is:

Produce animal meat while substantially reducing the need to breed, house and slaughter livestock.

What is microbial protein?

Microbial protein is produced by growing microorganisms such as:

  • Bacteria
  • Yeasts
  • Fungi
  • Microalgae

The microorganisms themselves become the source of protein.

Calysta's FeedKind process uses a naturally occurring bacterium, commonly identified in its scientific research as Methylococcus capsulatus, which is grown through controlled fermentation.

After growth and processing, the resulting ingredient contains concentrated protein, fat and other cellular components.

Innovation Type: Single-Cell Protein Fermentation

The central promise is different:

Create nutritionally useful protein without growing animals or conventional protein crops.

FeedKind is therefore closer conceptually to:

  • Yeast protein
  • Mycoprotein
  • Algal protein
  • Other biomass-fermentation ingredients

than to cultivated chicken.

FeedKind may actually be more radical than cultivated meat in one respect

Cultivated meat still begins with animal cells.

FeedKind does not.

Calysta says its process requires:

  • No animal ingredients
  • No plant ingredients
  • No arable land
  • Very little water

The microorganisms are supplied with a carbon and energy source inside a patented fermentation system. The resulting biomass is harvested as a high-protein feed ingredient.

Innovation Type: Agriculture-Independent Protein Production

This means FeedKind does not need:

  • Livestock farming
  • Soy fields
  • Pea fields
  • Fishmeal
  • Meat by-products

The process creates protein through industrial biology rather than agriculture.

MicroBell was the first complete dog food using FeedKind Pet

On February 27, 2025, Calysta and German pet-food company Marsapet announced MicroBell, sold through Marsapet's Marsavet veterinary-health line.

The companies described it as the first complete dog food containing FeedKind Pet protein.

The dry kibble was formulated as:

  • Vegan
  • Grain-free
  • Gluten-free
  • Nutritionally complete

Its main ingredients were described as:

  • Sweet potato
  • Peas
  • FeedKind protein
  • Potato

Calysta said the product contained the amino acids required to support a complete canine diet.

Brand: Marsavet

Product: MicroBell

Pet-food company: Marsapet

Protein partner: Calysta

Launch: February 27, 2025

Innovation Type: First Complete FeedKind-Based Dog Food

That is a genuine commercial first.

It simply is not a cultivated-meat first.

FeedKind had already appeared in dog treats

MicroBell was not the first pet product to use FeedKind.

In May 2024, Dr. Clauder's introduced an air-dried dog treat containing FeedKind Pet at Interzoo.

Calysta described it as the first dog treat made with the ingredient.

The commercial progression was therefore:

May 2024

First FeedKind-based dog treat announced.

August 2024

First major commercial shipment of FeedKind Pet arrived in Europe.

February 2025

First complete dog food containing FeedKind Pet launched.

Market Signal: Ingredient Moving From Demonstration to Daily Diet

Treats are a useful first commercial format because they represent a small proportion of total nutrition.

A complete food carries a much higher burden.

It must supply all nutrients required for the intended life stage when fed as the animal's primary diet.

Meatly reached the market first with actual cultivated meat

On February 7, 2025, British cultivated-meat company Meatly, dog-food brand The Pack and retailer Pets at Home began selling Chick Bites.

The treats combined:

  • Plant-based ingredients
  • Cultivated chicken produced by Meatly

The initial release was limited to one Pets at Home store in Brentford, England. The companies described it as the world's first commercial pet-food product containing cultivated meat.

Brand: The Pack

Product: Chick Bites

Cultivated-meat producer: Meatly

Launch: February 7, 2025

Format: Dog treat

Commercial scale: Limited single-store release

Innovation Type: First Retail Cultivated-Meat Pet Treat

This launch preceded MicroBell by approximately three weeks.

But the products occupied different categories:

Chick Bites was a treat containing cultivated animal cells.

MicroBell was a complete diet containing fermentation-derived microbial protein.

Meatly's chicken came from animal cells

Meatly said its cultivated chicken began with cells derived from a chicken egg.

The cells were grown with nutrients inside a controlled production system, creating chicken-cell biomass without repeatedly raising and slaughtering chickens.

The company claimed the ingredient contained amino acids, fatty acids, vitamins and minerals associated with chicken meat.

The important distinction is not whether the product was grown in a vessel.

Both cultivated cells and microorganisms can be grown in vessels.

The distinction is what is being grown:

  • Technology
  • Organism being grown
  • Result
  • Cultivated meat
  • Animal cells
  • Animal-cell biomass
  • FeedKind fermentation
  • Microorganisms
  • Microbial protein biomass
  • Precision fermentation
  • Engineered microbes producing a target molecule
  • Specific protein, fat or compound
  • Plant agriculture
  • Crops
  • Plant ingredients
  • Consumer Education Signal: "Fermented" Does Not Automatically Mean "Cultivated Meat"
  • Chick Bites was not a complete dog food

The initial Meatly launch was a treat.

The companies did not present Chick Bites as a product capable of supplying a dog's entire daily nutritional requirements.

That limitation matters when discussing "firsts."

A treat proves:

  • Regulatory acceptance
  • Ingredient production
  • Palatability
  • Retail feasibility
  • Consumer curiosity

A complete food must additionally prove:

  • Nutritional adequacy
  • Safe inclusion levels
  • Digestibility
  • Long-term feeding suitability
  • Consistent manufacturing
  • Evidence Distinction: First Treat Versus First Complete Diet
  • FORZA10 introduced a true complete cultivated-meat dog food

In May 2026, Italian pet-food brand FORZA10 introduced Coolty Meat at Interzoo in Nuremberg.

The wet dog food was developed with cultivated-meat technology company BeneMeat and contained 26% cultivated meat, according to company and trade-industry reporting.

It also contained ingredients including:

  • Vegetables
  • Pea protein
  • Brewers' yeast

The companies presented the product as nutritionally complete and suitable for regular feeding.

Brand: Coolty Meat / FORZA10

Cultivated-meat supplier: BeneMeat

Launch: May 2026

Format: Complete wet dog food

Cultivated-meat inclusion: 26%

Innovation Type: Complete Cultivated-Meat Pet Nutrition

This is much closer to the headline originally proposed.

A corrected version would be:

  • The First Complete Cultivated-Meat Dog Food Has Reached the European Market
  • FORZA10's "first" is still a company claim

Trade publications consistently describe Coolty Meat as the first commercial launch of a complete cultivated-meat dog food in the EU.

The wording should remain attributed to the companies because "first" claims can depend on:

  • Geographic scope
  • Definition of commercial availability
  • Whether the product is a treat or complete food
  • Whether a trade-show launch counts as full retail availability
  • Distribution scale
  • Whether the UK is included within "Europe" or separated from the EU

BeneMeat's own material describes the product as the first complete dog food of its kind to reach the European market.

Evidence Signal: Strongly Documented Company First Claim

Evidence Gap: Initial Retail Scale and Availability Require Continued Verification

The EU and Europe are not interchangeable

The UK approved Meatly's cultivated chicken for pet-food use in July 2024 and hosted the first commercial cultivated-meat pet treat in February 2025.

The UK is geographically European but is no longer part of the European Union.

BeneMeat became the first company to register cultivated-meat pet-food material in the EU feed-material system in 2023.

The sequence is therefore:

United Kingdom

First European regulatory approval and first commercial pet treat containing cultivated meat.

European Union

First registered cultivated-meat pet-food material, followed by the claimed first complete commercial product.

Database Correction: Separate UK, Europe and EU Claims

BeneMeat uses animal cells; FeedKind does not

The two technologies can now be compared clearly.

FeedKind Pet

Grows naturally occurring microorganisms

Does not use animal cells

Produces single-cell protein

Can support vegan product positioning

Uses fermentation as the primary production method

BeneMeat cultivated meat

Grows animal cells

Produces animal-cell biomass

Is meat biologically, despite avoiding conventional livestock production

Cannot accurately be described as vegan

Uses cell-culture technology

Trust Distinction: Animal-Free Protein Versus Slaughter-Free Animal Protein

Both may reduce reliance on conventional livestock.

Only one is actual meat.

"Cultured protein" is technically broad but commercially confusing

Calysta describes FeedKind as cultured protein.

That wording is technically defensible because the microorganisms are cultured.

But consumers increasingly associate "cultured" with:

  • Cultured meat
  • Cell-cultivated chicken
  • Lab-grown beef

Using the same term across microbial biomass and animal-cell cultivation can create confusion.

Risk Signal: Shared Language Across Different Technologies

A clearer classification system would use:

  • Microbial protein
  • Fermentation-derived protein
  • Single-cell protein

for FeedKind, and:

  • Cultivated meat
  • Cell-cultured meat
  • Animal-cell biomass

for Meatly and BeneMeat.

Dogs need nutrients, not a culturally defined meat ingredient

A dog's nutritional requirement is not for a named ingredient such as chicken breast.

It is for an appropriate balance of:

  • Essential amino acids
  • Fatty acids
  • Vitamins
  • Minerals
  • Energy
  • Fibre
  • Other nutrients

A complete diet can theoretically use different ingredient systems if the finished formulation meets the animal's nutritional requirements and is digestible, safe and palatable.

Nutrition Signal: Biological Requirement Is Nutrient-Based

This makes pet food a potentially attractive early market for alternative proteins.

The ingredient does not need to recreate the visual structure of a steak.

It may be processed into:

  • Kibble
  • Wet food
  • Treats
  • Toppers
  • Nutritional pastes

Texture replication is less demanding than in cultivated meat intended for a human restaurant.

FeedKind now has published dog-safety data

A 2025 peer-reviewed study evaluated FeedKind Pet in adult dogs.

Thirty-two healthy adult beagles received diets containing up to 8% FeedKind protein during a six-month feeding period, followed by a two-month control period.

The researchers assessed:

  • General health
  • Body weight
  • Feed intake
  • Digestibility
  • Blood and clinical measures
  • Faecal microbiome effects

The study reported that the ingredient was well tolerated at the tested inclusion levels.

Protein and energy digestibility exceeded 80%, while fat digestibility exceeded 90%. The dogs maintained normal weight and body-condition measures, and the study reported microbiome changes that the researchers considered potentially beneficial.

Evidence Signal: Six-Month Target-Animal Safety Study

Evidence Limitation: One Ingredient Study Does Not Validate Every Final Product

The findings support FeedKind as an ingredient.

They do not automatically prove that every formula containing it is nutritionally complete.

The FeedKind study had commercial involvement

The research concerns a proprietary Calysta ingredient and was connected to the company's regulatory and commercial development programme.

That does not make the results invalid.

It does mean the evidence should be interpreted with:

  • Funding disclosure
  • Author-affiliation review
  • Attention to study design
  • Independent replication

Evidence Principle: Peer Review Strengthens the Claim; Independent Replication Strengthens It Further

The study involved healthy adult dogs.

It does not automatically establish suitability for:

  • Puppies
  • Pregnant dogs
  • Dogs with kidney disease
  • Dogs with food allergies
  • Every breed
  • Lifelong exclusive feeding at every inclusion level
  • FeedKind has a complete amino-acid profile—but the finished diet still matters

Calysta describes FeedKind Pet as having a complete amino-acid profile and sufficient nutritional density to support complete pet-food formulations.

The ingredient contains high levels of crude protein and some fat.

But dogs do not eat isolated protein in real life.

The complete formula must balance:

  • Protein quality
  • Total amino-acid supply
  • Fatty acids
  • Calcium and phosphorus
  • Vitamins
  • Trace minerals
  • Energy density
  • Fibre
  • Palatability
  • Evidence Correction: Protein Equivalence Is Not Complete-Diet Equivalence

A nutritionally strong protein ingredient can still be used inside a poorly formulated diet.

Cultivated meat also needs complete nutritional characterisation

BeneMeat presents its cultivated material as a nutritious source of animal protein.

The ingredient must still be characterised for:

  • Amino-acid composition
  • Fat profile
  • Vitamins
  • Minerals
  • Nucleic-acid content
  • Digestibility
  • Processing stability
  • Microbiological safety
  • Batch consistency

Cultivated meat may resemble conventional meat biologically.

It is not automatically nutritionally identical.

Differences can emerge from:

  • Cell line
  • Growth medium
  • Harvest stage
  • Processing
  • Added nutrients
  • Fat-cell content
  • Moisture
  • Final inclusion rate
  • Evidence Gap: Product-Specific Nutritional Equivalence Requires Direct Measurement
  • "No arable land" applies to FeedKind's core fermentation—not necessarily every input

Calysta says FeedKind production uses no agricultural land because the microorganisms are not fed crops such as soy, wheat or peas.

That is a meaningful distinction.

However, a complete lifecycle assessment must consider the sources of:

  • Energy
  • Carbon feedstock
  • Nitrogen
  • Minerals
  • Fermentation equipment
  • Processing
  • Drying
  • Transport

The Carbon Trust previously assessed FeedKind's environmental footprint and reported substantially lower water use than several conventional protein ingredients, along with very low agricultural-land requirements.

Evidence Signal: Strong Land-Use Advantage

Evidence Limitation: "No Arable Land" Is Not the Same as "No Environmental Footprint"

Fermentation remains an industrial process requiring energy and infrastructure.

Methane-derived protein raises a different sustainability question

FeedKind's process has historically used methane or natural gas as a carbon and energy source for methane-consuming bacteria.

This avoids agricultural land but creates questions about:

  • Fossil versus renewable methane
  • Methane leakage
  • Energy source
  • Carbon intensity
  • Facility location
  • Process efficiency
  • Sustainability Trade-Off: Land Independence Versus Carbon-Source Dependence

The environmental result can vary substantially depending on whether the methane comes from:

  • Fossil natural gas
  • Biogas
  • Captured waste methane
  • A lower-carbon industrial source

The strongest future version of the technology may pair microbial fermentation with renewable or waste-derived carbon.

FeedKind is already operating at industrial scale

Calysta and Adisseo developed the Calysseo production facility in Chongqing, China.

Calysta described the initial facility as capable of producing approximately 20,000 tonnes of FeedKind protein annually.

By 2024, commercial tonnes of FeedKind Pet were being shipped from the facility to Europe through a warehouse in Poland.

Scale Signal: Tens of Thousands of Tonnes of Fermentation Capacity

That places FeedKind in a different commercial position from many cultivated-meat companies.

Cultivated meat remains constrained by:

  • Cell-culture-media cost
  • Bioreactor productivity
  • Sterility
  • Scale-up
  • Capital requirements
  • Regulatory approval

FeedKind's microbial process is closer to established industrial fermentation.

The 20,000-tonne figure is not necessarily all available for pet food

The Chongqing facility was initially built primarily around aquaculture-feed applications.

FeedKind Pet uses the same broad protein platform, but public materials do not establish that the full 20,000-tonne annual capacity is dedicated to companion-animal food.

The responsible wording is:

Calysta has access to industrial-scale FeedKind production capacity, while the exact current volume allocated to pet-food customers is not publicly disclosed.

Evidence Gap: Pet-Specific Production Volume and Unit Economics Not Public

This is central to the original research recommendation.

Commercial-scale fermentation does not automatically reveal:

  • Ingredient price per kilogram
  • Minimum order volume
  • Cost relative to chicken meal
  • Cost relative to soy protein
  • Cost after transport
  • Margin in finished dog food
  • Cultivated meat remains much more constrained by economics

Meatly's Chick Bites launch was intentionally limited.

The product was sold at one store, and Meatly said wider availability would depend on scaling production over the following years.

This illustrates the category's central economic challenge.

A product can be:

  • Technically feasible
  • Approved
  • Nutritionally promising
  • Commercially launched

without being available at mass-market volume or price.

Market Signal: Commercial Launch Does Not Equal Commercial Scale

FORZA10's 2026 launch represents another important step, but the initial distribution scale and unit economics remain unclear.

Pet food may be the fastest route to cultivated-meat scale

The economics of pet food differ from human meat.

Pet products can use cultivated biomass as:

  • A minority inclusion
  • A protein component
  • A palatability enhancer
  • A functional ingredient
  • Part of a blended formula

The product does not need to recreate:

  • Muscle fibres
  • Marbling
  • Steak structure
  • Human culinary texture
  • Innovation Advantage: Biomass Is Valuable Without Whole-Cut Structure

That could allow cultivated-meat companies to reach commercial relevance in pet food earlier than in mainstream human meat.

A 26% inclusion level is commercially significant

Coolty Meat reportedly contains 26% cultivated meat.

That is much more substantial than using a trace amount simply to support a futuristic claim.

At the same time, the product is still a blended food containing plant and fermentation-derived ingredients.

Commercial Signal: Cultivated Protein as Major Ingredient, Not Entire Formula

The formulation demonstrates how early cultivated-meat products are likely to develop:

Cultivated cells + conventional nutrients + plant ingredients + functional processing components

rather than 100% cultivated meat.

Alternative protein may be especially useful for food intolerance

FORZA10 has associated Coolty Meat with a monoprotein positioning and dogs with food sensitivities.

A novel protein source could theoretically be useful when a dog has previously been exposed to common proteins such as:

  • Chicken
  • Beef
  • Lamb

However, cultivated meat still originates from an animal species.

A dog allergic to a conventional species protein may potentially react to related proteins from cultivated cells.

Risk Signal: Novel Production Method Does Not Automatically Mean Hypoallergenic

Any food-intolerance or allergy positioning requires product-specific veterinary evidence.

"Slaughter-free" is more accurate than "animal-free" for cultivated meat

Cultivated meat may dramatically reduce the number of animals required.

But animal cells are still part of the production origin.

Depending on the company and process, animal-derived components may also be relevant to:

  • Initial cell sourcing
  • Cell banking
  • Growth media
  • Research stages

Modern cultivated-meat companies increasingly aim to avoid fetal bovine serum and other animal-derived growth inputs.

BeneMeat describes its approach as designed around scalable, serum-free production, but complete technical details remain proprietary.

Evidence Correction: Cultivated Meat Is Not Necessarily Animal-Free

FeedKind can support a vegan claim.

Cultivated meat generally supports a slaughter-reduction claim.

The environmental case must be tested at commercial scale

BeneMeat says it has completed a peer-reviewed lifecycle assessment indicating reduced land use and emissions compared with conventional animal protein.

Cultivated-meat sustainability depends heavily on:

  • Energy source
  • Bioreactor efficiency
  • Growth-medium ingredients
  • Facility scale
  • Cooling and sterilisation
  • Cell density
  • Product yield

A small efficient pilot does not guarantee the same impact at large scale.

Evidence Signal: Early Lifecycle Evidence

Evidence Gap: Independently Replicated Commercial-Scale Footprint

The same caution applies to fermentation protein.

Alternative does not automatically mean lower impact under every production scenario.

Consumer acceptance may depend on terminology

Pet owners may react differently to the terms:

  • Lab-grown meat
  • Cultivated meat
  • Cell-cultured chicken
  • Fermented protein
  • Microbial protein
  • Single-cell protein

"Lab-grown" communicates novelty but may create concern.

"Fermented" feels familiar but may obscure the underlying organism.

"Cultivated meat" is more precise for animal-cell products.

Consumer Psychology Signal: Technology Name Shapes Trust

Brands will need to explain:

  • What is being grown
  • What the finished ingredient contains
  • Why it is safe
  • How it is nutritionally evaluated
  • Whether animals are involved
  • Why the process is environmentally different
  • Veterinary confidence will require more than sustainability claims

Pet owners may like the environmental proposition.

Veterinarians will focus on:

  • Nutritional adequacy
  • Digestibility
  • Palatability
  • Long-term safety
  • Manufacturing quality
  • Contaminant controls
  • Life-stage suitability
  • Clinical outcomes
  • Trust Mechanism: Veterinary Nutrition Evidence

FeedKind now has a substantial six-month canine ingredient study.

Cultivated-meat products need similarly transparent evidence covering the exact commercial formulas.

The strongest category comparison is not "meat versus fake meat"

The emerging protein landscape includes several distinct systems:

  • Protein system
  • Biological source
  • Main advantage
  • Main challenge
  • Conventional meat
  • Farmed animals
  • Familiar nutrition and taste
  • Land, emissions and animal welfare
  • Meat by-products
  • Existing animal-food chain
  • Resource efficiency
  • Consumer perceptions and supply dependence
  • Plant protein
  • Crops
  • Established scale
  • Amino-acid balance and palatability
  • Insect protein
  • Farmed insects
  • Feed efficiency
  • Consumer acceptance and regulation
  • Microbial protein
  • Fermented microorganisms
  • Minimal agricultural land
  • Carbon and energy inputs
  • Cultivated meat
  • Animal cells
  • Animal protein with reduced livestock use
  • Cost and scale
  • Innovation Territory: Multi-Protein Pet-Food Architecture

The future is unlikely to depend on one universal replacement.

Brands may combine several systems.

The real 2025 breakthrough was two technologies reaching shelves together

February 2025 should be remembered for two separate milestones.

February 7

Meatly and The Pack sold the first limited commercial dog treat containing cultivated chicken.

February 27

Calysta and Marsapet launched the first complete dog food containing FeedKind microbial protein.

The timing made it easy to collapse both into one "lab-grown pet food" story.

They represent different futures.

Meatly asks:

Can we produce real animal cells without conventional livestock farming?

Calysta asks:

  • Do we need animal cells at all to produce high-quality protein?
  • FORZA10 added the missing complete-food milestone

The 2026 Coolty Meat launch filled the gap between:

  • A cultivated-meat treat
  • A complete diet

It demonstrated that cultivated meat could become a significant component of a nutritionally complete wet dog food rather than a novelty snack.

That is the category-defining development originally intended by the database row.

Signal: Cultivated Meat Moving From Treat to Complete Nutrition

The "first" story should become a timeline, not a single winner

A more accurate innovation timeline is:

May 2024

Dr. Clauder's announces the first dog treat using FeedKind fermented microbial protein.

July 2024

The UK approves Meatly cultivated chicken for pet-food use.

August 2024

Calysta ships commercial quantities of FeedKind Pet into Europe.

February 7, 2025

Meatly, The Pack and Pets at Home launch Chick Bites, the first commercially sold pet treat containing cultivated meat.

February 27, 2025

Marsapet launches MicroBell, the first complete dog food containing FeedKind Pet microbial protein.

May 2026

FORZA10 and BeneMeat launch Coolty Meat, described as the first complete cultivated-meat dog food commercially introduced in the EU.

Evidence Signal: Multiple Firsts Across Technology, Format and Geography

The category's biggest shift is that protein no longer has to begin on a farm

For most of pet-food history, protein came from:

  • Livestock
  • Fish
  • Crops

The new systems add two entirely different production routes:

  • Grow microorganisms
  • Grow animal cells

Neither has yet displaced conventional protein at mass scale.

But both have crossed the boundary from laboratory development into commercial products.

That makes the story bigger than one dog-food launch.

The pet-food industry is beginning to treat protein as something that can be programmed and manufactured through biology rather than harvested only from agriculture.

The first lab-grown dog food did launch

It simply was not FeedKind.

The most accurate conclusions are:

Meatly's Chick Bites was the first commercial pet-food product containing cultivated meat, launched in the UK in February 2025.

Marsapet MicroBell was the first complete dog food containing Calysta's fermentation-derived FeedKind Pet protein, launched later that month.

FORZA10 Coolty Meat became the claimed first complete cultivated-meat dog food launched in the EU in May 2026.

The original finding identified a real transformation.

It assigned the wrong technology to the wrong product.

That correction makes the story more interesting, not less.

The pet-food category is not pursuing one replacement for conventional meat.

It is developing two competing biological answers to the same question:

Can we feed dogs high-quality protein without raising and slaughtering animals at today's scale?

One answer grows meat cells.

The other grows protein-producing microbes.

Both Calysta's FeedKind and cultivated meat have now reached the market.

Brand Radar Signal Tags

Brands and Organisations

CalystaFeedKindMarsapetMarsavetDr. Clauder'sMeatlyThe PackPets at HomeFORZA10Coolty MeatBeneMeatCalysseoAdisseo

Products

Marsavet MicroBellFeedKind Pet ProteinChick BitesMeatly Cultivated ChickenFORZA10 Coolty MeatDr. Clauder's FeedKind Dog Treats

Technology Types

Cultivated MeatCell-Cultured MeatAnimal-Cell AgricultureMicrobial FermentationSingle-Cell ProteinBiomass FermentationFermentation-Derived ProteinCellular Agriculture

Commercial Firsts

First Commercial Cultivated-Meat Pet TreatFirst Complete FeedKind Dog FoodFirst Complete Cultivated-Meat Dog Food in the EUFirst EU-Registered Cultivated-Meat Pet-Food MaterialFirst Commercial FeedKind Pet Shipments

Nutritional Signals

Complete Amino-Acid ProfileProtein Digestibility Above 80%Fat Digestibility Above 90%Six-Month Canine Feeding StudyComplete and Balanced Dog Food26% Cultivated-Meat Inclusion

Sustainability Signals

No Agricultural Land for FeedKind FermentationMinimal Water Use ClaimNo Animal Ingredients in FeedKindReduced Livestock DependenceSlaughter-Free Animal ProteinIndustrial FermentationCultivated-Meat Lifecycle Assessment

Market Signals

Alternative Protein CommercialisationPet Food as Cultivated-Meat Entry MarketTreat-to-Complete-Diet ProgressionIndustrial-Scale Microbial ProteinLimited-Scale Cultivated-Meat LaunchProtein Production Beyond Agriculture

Evidence Signals

Peer-Reviewed FeedKind Dog StudyCommercially Shipped FeedKind TonnesCultivated-Meat Retail LaunchCompany-Claimed EU FirstPet-Specific Production Economics Not PublicLong-Term Cultivated-Meat Feeding Evidence Needed

Risk Signals

FeedKind Mistaken for Cultivated MeatCultured Protein Terminology ConfusionCommercial Launch Mistaken for Mass ScaleIngredient Evidence Applied to Finished DietSlaughter-Free Mistaken for Animal-FreeNovel Protein Mistaken for HypoallergenicEnvironmental Claim Without Full Energy ContextCompany-Funded Evidence Requires Replication

Sources

Calysta and FeedKind

Calysta—Marsapet launch announcement: Confirms the February 27, 2025 launch of MicroBell as the first complete dog food featuring FeedKind Pet and describes the food as vegan, grain-free and gluten-free. https://calysta.com/marsapet-launches-first-dog-food-featuring-feedkind-pet-protein/

FeedKind product overview: Describes FeedKind as a non-GMO protein produced through natural fermentation without animal-derived ingredients.

FeedKind Pet technical overview: Identifies controlled microbial fermentation, a complete amino-acid profile and claimed minimal agricultural-land and water use.

Calysta commercial shipment announcement: Confirms commercial tonnes of FeedKind Pet were shipped from the Chongqing production facility to Europe in 2024.

Carbon Trust assessment: Reports substantially lower water use and minimal agricultural-land requirements compared with several conventional protein ingredients.

FeedKind dog-nutrition evidence

Longshaw et al., 2025—Animals: Evaluates FeedKind Pet safety, digestibility and microbiome effects in adult dogs during a six-month feeding period.

Calysta research summary: Reports protein and energy digestibility above 80%, fat digestibility above 90% and normal health and body-condition findings at tested inclusion levels.

Meatly cultivated-meat launch

The Verge—Chick Bites launch: Confirms the February 7, 2025 limited UK retail release and distinguishes the cultivated-chicken ingredient from the product's plant-based components.

The Guardian—First cultivated-meat dog treat: Reports the limited retail launch and Meatly's cell-cultivated chicken process.

The Guardian—UK regulatory approval: Reports the UK's July 2024 approval of Meatly cultivated chicken for pet food.

FORZA10 and BeneMeat

FORZA10 Coolty Meat: Official product material describes the cultivated-meat partnership and BeneMeat's EU feed-material registration.

BeneMeat: Describes Coolty Meat as the first complete cultivated-meat dog food of its kind to reach the European market.

Petfood Industry: Reports that the complete wet food contains 26% cultivated meat and was commercially introduced at Interzoo 2026.

Pet Food Processing: Reports the companies' claim that Coolty Meat was the world's first commercial complete-and-balanced pet food made with cultivated meat.

Ingredients Network: Provides additional formulation information and describes the product as a complete cultivated-meat dog food.

What brands should watch
  • 01Separate 'cultured meat treat' from 'complete cultured meat diet' — the regulatory, cost and nutrition gaps between them are enormous.
  • 02The near-term wedge is treats and toppers, where cost-per-gram is tolerable and complete-nutrition rules don't apply.
  • 03Watch for cultured-meat inclusion percentages on-pack; single-digit inclusions will be the honest first-generation claim.
  • 04Retail buyers will demand supply-chain provenance documentation before shelving the category at scale.
Method — story built from 0 tracked signals · Confidence Medium
Related stories
BrandRADAR
Innovation intelligence briefing for consumer goods professionals. Published by ConsensysAI.
© 2026 ConsensysAI·Innovation intelligence